StockWatch
·

ISGEC Heavy Engineering Ltd Q2 FY27 Results

ISGECQ2 FY27 Results
Filing
Result:Good· Market: Up#Broad based#Margin expansion

Outlook: Cautiously Optimistic · Guidance: Raised

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.9K6.5%9.4%
Total Income1.9K6.7%7.8%
Expenditure1.8K9.4%10.6%
PBT102.2693.3%24.8%
Net Profit66.19278.2%17.6%
OPM7.96%1.72pp0.76pp
NPM3.56%2.68pp0.30pp
EPS7.67528.7%34.2%
View full financials

Standalone revenue grew 17.2% YoY — well ahead of FY27 guidance — with manufacturing/projects segment margins landing right on the 12-13%/5-6% guided bands and consolidated margins improving sequentially, though consolidated OPM is still down YoY and no Street estimate exists to call beat/miss.

ISGEC HEAVY ENGINEERING LTD · QQ2 FY-2027 · THE CALL

Record order book, but delivery growth trails guidance

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

12 Nov 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Met manufacturing margin guidance (13.7%). Missed prior 10-12% consolidated revenue growth (9.4% delivered). Projects margin 5.7% vs 6% target is on track.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Strong order book (₹8,757 Cr) and capex momentum support medium-term upside, but Q2 delivered consolidated growth of 9.4% YoY trails the prior 10-12% guidance and upcoming 15-17% target. Subsidiary drag (Philippines -₹164 Cr, Saraswati weak) masks standalone strength. Margin expansion in core manufacturing (13.7% vs 12-13% guided) offset by near-term execution risk.

₹1850.4 Cr

Revenue · +9.4% YoY

₹66.2 Cr

Reported PAT · +17.6% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Revenue grew 17% YoY for the quarter

OVERSTATED

Standalone grew 17% but consolidated delivered 9.4% growth YoY

Manufacturing EBIT margin 13.7% beats 12-13% guidance

MET

Q2 manufacturing margin 13.7% vs guided 12-13% range

Order book at all-time high ₹8,757 Cr

MET

Sep 30, 2026 order book confirmed ₹8,757 Cr closing position

Projects EBIT margin 5.7% vs 6% target

MET

Delivered 5.7%, tracking toward 6% by year-end

Earnings quality

What changed since the last call

Deltas vs. the prior call

Revenue growth guidance raised

Upgrade

Prior call: 10-12% FY27 standalone. This call: 15-17%. Delivered Q2: 9.4% consolidated. Upgrade driven by order book visibility (₹4,844 Cr H1 booking) vs prior uncertainty. Gap reflects subsidiary headwinds.

Manufacturing margin beat

Upgrade

Q2 13.7% vs 12-13% guided. Projects margin 5.7% vs 6% on track. Indicates pricing power & cost control despite commodity inflation.

Capex trajectory firmed

Neutral

Maintained ₹502 Cr capex for ₹1,200 Cr revenue potential by FY29. New facilities (Bhartoli, SEZ, Dabhei, Ratangarh, Hawa) on schedule. Management evaluating potential to increase from ₹500 Cr mentioned.

Subsidiary losses crystallized

Downgrade

Philippines ethanol cumulative -₹164 Cr H1 loss (depreciation, interest, forex). Saraswati Sugar -₹60 Cr PBIT H1 vs prior strength. Consolidated growth 9.4% YoY vs standalone 17%, confirming ~750-800 bps drag.

The Q&A

Analyst Manish Goyal pressed aggressively on 15% guidance vs incremental H1 growth already achieved. Management held firm, citing second half smaller but defended full-year. On Philippines, management was evasive (blamed depreciation method change, seasonal feedstock). Direct questions on Saraswati supply, Hitachi JV margins drew guarded responses. Q&A showed confidence on order execution but limited transparency on subsidiary path to profitability.

The exchanges that mattered

Revenue growth guidance credibility — Manish Goyal, Thingwise Wealth Managers

Partial

H1 was 3,000 Cr, H2 expected 3,200-3,300 Cr run rate. Small H2 growth but strong order pipeline justifies guidance. Base already higher, so % growth lower. Second half orders converting gradually.

Cavite Biofuel depreciation volatility — Manish Goyal, Thingwise Wealth Managers

Answered

Changed depreciation method externally reviewed. Q2 depreciation ₹8 Cr for Cavite Biofuel. Expect ₹8 Cr/quarter Q3-Q4. Cumulative ~₹175 Cr for H1 impact from method change.

Hitachi JV margin pressure — Manish Goyal, Thingwise Wealth Managers

Dodged

Strong order book, margins expected higher maybe 5-7% vs last year. Booked large export orders, export base growing. Expect turnover ~7-8% higher vs prior year.

Products division order composition — Digant Haria, Greenedge Wealth

Answered

Orders from auto, oil & gas, petrochem, cement, steel. Wide industry spread. Expansions on schedule. ₹1,200 Cr annual revenue potential from ₹502 Cr capex. Some revenue coming this year, bulk next 2-3 years.

Saraswati Sugar Mills cane supply — Sandeep Baid, Individual

Partial

Located Haryana. Supply not enough this season. Expect marginally more cane than last year. Real production starts December. Q4 utilization ~90%. Commodity prices firm, should improve realization.

Philippines ethanol unit path to breakeven — Rabindra Nath Nayak, Nirmal Bang

Dodged

Plant under maintenance Q3. Feedstock available December when sugarcane season starts. Q3 70-75% utilization, Q4 90% expected. No quarterly loss guidance; depreciation ₹8 Cr, interest clear, forex unclear.

Capex increase potential — Bajrang Bafna, Sunidhi Securities

Partial

₹500 Cr program will yield ₹1,200 Cr incremental revenue. Evaluating if we might top it up, not finalized. FY29 target if all on schedule. Only small revenue <₹100 Cr this year; bulk next 2 years.

Order book fixity & price variation — Digant Haria, Greenedge Wealth

Answered

Most orders fixed-price. Limited price variation. Manage via back-to-back quotes, rate contracts, contingencies. Risk mitigation via short-cycle orders to reduce customer liquidity risk.

Guidance

Forward guidance and management's confidence

FY27 standalone revenue growth 15-17% (raised)

Medium

Prior guidance 10-12%. Upgrade driven by ₹4,844 Cr order booking visibility. But consolidated delivered 9.4%, indicating 5-7% subsidiary drag. Second half must deliver 3,200-3,300 Cr to hit target. Execution risk: Philippines ramp, Saraswati supply.

Manufacturing EBIT 12-13% (maintained, already beat to 13.7%)

High

Q2 achieved 13.7%, indicating pricing power. Expected to stay 12-13% range for full year despite commodity inflation headwinds. Input cost inflation partially offset by short-cycle order mix.

Projects EBIT margin to improve to ~6% by year-end (from 5.7%)

Medium

Currently 5.7% vs 6% target. Management expects margin expansion as capex benefits materialize and technology pivot to shorter-cycle orders accelerates. Execution dependent on order execution pace.

₹502 Cr capex expansion for ₹1,200 Cr annual revenue potential by FY29

Medium

All new facilities (Bhartoli, SEZ Dabhei, Ratangarh, Hawa) running on schedule, progressively completing through Q4 FY27. Management evaluating potential increase from ₹500 Cr baseline. Revenue contribution <₹100 Cr FY27, bulk in FY28-29.

Risks the call surfaced

Ranked by how much they should concern a holder

Philippines biofuel losses

High

Cavite Biofuel ethanol plant incurred ₹164 Cr cumulative loss H1 (depreciation ₹50+, interest, forex loss). Operating at 65-70% capacity on molasses feedstock. Real sugarcane-based production starts December. Path to profitability unclear; management evasive on quarterly loss guidance.

Saraswati Sugar Mills cane supply

Medium

H1 PBIT loss ₹60 Cr due to lower cane availability (67 Cr units vs 70+ normal) in Haryana captive area. Lower production & realizations drove margin compression. Supply dependent on weather & farmer planting patterns.

Consolidated vs standalone divergence

Medium

Standalone revenue grew 17% YoY but delivered consolidated result shows only 9.4% growth. ~750 bps gap driven by Philippines & Saraswati drag. If standalone growth guidance (15-17%) is maintained while subsidiaries remain weak, consolidated may miss 10-12% prior guidance again.

Geopolitical & commodity inflation

Medium

Material cost inflation (steel, copper, aluminum) skewed up 10% YoY due to Middle East tensions. Shipping delays, higher freight surcharges. Management notes most increased costs absorbed via contingency provisions, but longer-term margin risk if inflation persists.

Capex materialization timeline

Medium

₹502 Cr capex targeting ₹1,200 Cr annual revenue by FY29. Only <₹100 Cr revenue expected FY27, bulk in FY28-29. Execution delays would push realization further. Management evaluating increase from ₹500 Cr but no decision finalized.

Management

Score 7/10. Clear on order pipeline & capex. Transparent on manufacturing margin beat. Evasive on Philippines ethanol ramp timeline & quarterly loss path. Limited disclosure on product-wise revenue/margin breakdown. NDA-shields product division strategy; candid on capex spend & timeline. Beat manufacturing margin guidance (13.7% vs 12-13%). Order book at all-time high ₹8,757 Cr indicates strong execution. Missed consolidated revenue growth (9.4% vs prior 10-12% target). Subsidiary performance drag not fully explained. Capex facilities on schedule but realization timing uncertain (FY28-29 vs FY29).

What to watch next
  • 1 · Q3 FY27 (Dec 2026)

    Cavite biofuel depreciation stabilizes; Philippines ethanol real production begins post-sugarcane start

  • 2 · Q4 FY27 (Mar 2027)

    Saraswati Sugar Mills capacity utilization improves; new manufacturing capacity from Bhartoli, SEZ, Dabhei commences

  • 3 · FY28-29

    ₹502 Cr capex materialization: ₹1,200 Cr incremental revenue target from new press, skids, modules facilities

Margin expansion in core manufacturing (13.7% vs 12-13% guided) offset by near-term execution risk.

Informational and educational content only. Not investment advice.